High Plasma GFAP Level Predicts Disability in Progressive MS

A high level of glial fibrillary acidic protein (GFAP) in the blood may predict worsening disability in patients with secondary progressive multiple sclerosis (MS), according to investigators.
Medscape Medical News

Source link

Related posts

A case of segmental arterial mediolysis with widespread involvement of cranial and abdominal arteries


How soon is soon enough to learn you have Alzheimer’s?


Insular and anterior cingulate cortex deep stimulation for central neuropathic pain: Disassembling the percept of pain


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World